On April 7, in a decision replete with “junk science,” Texas federal district court judge Mathew Kacsmaryk issued an unprecedented ruling revoking the FDA’s 2000 approval of mifepristone. The Supreme Court has since blocked his order while the appeal is pending—a somewhat hopeful sign, beyond the immediate benefit of mifepristone remaining available on the market for now—until there’s a final ruling on the merits of the case. But there is no way of knowing with certainty what the outcome of the case will be, and whether any elements of Kacsmaryk’s decision will remain standing as good law. 

We’re still far from the final word on what could ultimately be a legal advance of the religiously inspired ‘abortion regret’ narrative.